Literature DB >> 19740096

A platelet tetraspanin superfamily member, CD151, is required for regulation of thrombus growth and stability in vivo.

E Orlowski1, R Chand, J Yip, C Wong, M W Goschnick, M D Wright, L K Ashman, D E Jackson.   

Abstract

BACKGROUND: This study was designed to determine the role of CD151 in platelet thrombus formation in vivo and define the contribution of platelet vs. endothelial CD151 in regulating platelet thrombus formation in vivo. METHODS AND
RESULTS: Using intravital microscopy and ferric chloride (FeCl(3)) injury of mesenteric arterioles, we found that thrombi formed in CD151(+/-) and CD151(-/-) mice were smaller and less stable, than those formed in CD151(+/+) mice, with a tendency for embolization. Similarly, in Folt's FeCl(3)-induced carotid injury model, both CD151(+/-) and CD151(-/-) mice showed more prolonged times to 95% vessel occlusion than CD151(+/+) mice. In addition, laser-induced injury of cremaster muscle arterioles showed that thrombi formed in CD151(+/-) and CD151(-/-) mice were smaller and less stable than those formed in CD151(+/+) mice. Following platelet depletion/reconstitution with ex vivo-labeled donor platelets, platelet-depleted CD151(+/+) mice that received reconstitution with CD151(-/-) platelets had smaller thrombi that were unstable and embolized. In contrast, platelet-depleted CD151(-/-) mice that received reconstitution with CD151(+/+) platelets had normal thrombi that were stable.
CONCLUSIONS: These data provide evidence that platelet CD151 is required for regulating thrombus formation in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740096     DOI: 10.1111/j.1538-7836.2009.03612.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  16 in total

1.  Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin.

Authors:  Shannin Zevian; Nicole E Winterwood; Christopher S Stipp
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

Review 2.  Tetraspanin proteins promote multiple cancer stages.

Authors:  Martin E Hemler
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

3.  CD151: Basis Sequence: Mouse.

Authors:  Trenis D Palmer; Andries Zijlstra
Journal:  AFCS Nat Mol Pages       Date:  2011

Review 4.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

5.  The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression.

Authors:  Elizabeth J Haining; Jing Yang; Rebecca L Bailey; Kabir Khan; Richard Collier; Schickwann Tsai; Steve P Watson; Jon Frampton; Paloma Garcia; Michael G Tomlinson
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 6.  Mouse laser injury models: variations on a theme.

Authors:  Timothy J Stalker
Journal:  Platelets       Date:  2020-04-16       Impact factor: 3.862

7.  Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.

Authors:  S Mosawy; D E Jackson; O L Woodman; M D Linden
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

8.  CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.

Authors:  Musaed M Alshahrani; Eunice Yang; Jana Yip; Simona S Ghanem; Simon L Abdallah; Anthony M deAngelis; Cindy J O'Malley; Fatemeh Moheimani; Sonia M Najjar; Denise E Jackson
Journal:  Blood       Date:  2014-08-01       Impact factor: 22.113

9.  Vessel wall BAMBI contributes to hemostasis and thrombus stability.

Authors:  Isabelle I Salles-Crawley; James H Monkman; Josefin Ahnström; David A Lane; James T B Crawley
Journal:  Blood       Date:  2014-03-13       Impact factor: 22.113

10.  CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.

Authors:  Jianjie Zhu; Tingting Cai; Jieqi Zhou; Wenwen Du; Yuanyuan Zeng; Ting Liu; Yulong Fu; Yue Li; Qian Qian; Xiuwei H Yang; Qinglin Li; Jian-An Huang; Zeyi Liu
Journal:  J Exp Clin Cancer Res       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.